Shares of ANGLE plc (LON:AGL – Get Free Report) shot up 14.3% on Tuesday . The company traded as high as GBX 12.99 ($0.16) and last traded at GBX 12.58 ($0.16). 1,308,476 shares were traded during mid-day trading, an increase of 96% from the average session volume of 666,717 shares. The stock had previously closed at GBX 11 ($0.14).
Wall Street Analyst Weigh In
Separately, Berenberg Bank reissued a “buy” rating and set a GBX 70 ($0.86) target price on shares of ANGLE in a research note on Thursday, September 26th.
Read Our Latest Analysis on ANGLE
ANGLE Trading Up 13.6 %
ANGLE Company Profile
ANGLE plc, a medical diagnostic company, engages in developing cancer diagnostics products in Europe, North America, and the United Kingdom. The company develops and commercializes Parsortix cell separation system, which captures and harvests circulating tumor cells in metastatic breast cancer patient blood; and HyCEAD.
Recommended Stories
- Five stocks we like better than ANGLE
- What Are the FAANG Stocks and Are They Good Investments?
- SAP’s Strong Momentum: A Bullish Setup for Investors
- Stock Market Holidays 2022-2025 – Here’s When the NYSE and NASDAQ Will be Closed
- BlackRock Breaks Records: Why the Stock Still Has Room to Run
- What is the Dogs of the Dow Strategy? Overview and Examples
- Duke vs. NRG: Which Energy Stock Will Power Higher Gains?
Receive News & Ratings for ANGLE Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ANGLE and related companies with MarketBeat.com's FREE daily email newsletter.